Tabella, E.; Correale, M.; Alcidi, G.; Pugliese, R.; Ioannoni, S.; Romano, M.; Palmieri, G.; Di Biase, M.; Brunetti, N.D.; Iacoviello, M.
Introduction of SGLT2 Inhibitors and Variations in Other Disease-Modifying Drugs in Heart Failure Patients: A Single-Centre Real-World Experience. Clin. Pract. 2023, 13, 1015-1024.
https://doi.org/10.3390/clinpract13050090
AMA Style
Tabella E, Correale M, Alcidi G, Pugliese R, Ioannoni S, Romano M, Palmieri G, Di Biase M, Brunetti ND, Iacoviello M.
Introduction of SGLT2 Inhibitors and Variations in Other Disease-Modifying Drugs in Heart Failure Patients: A Single-Centre Real-World Experience. Clinics and Practice. 2023; 13(5):1015-1024.
https://doi.org/10.3390/clinpract13050090
Chicago/Turabian Style
Tabella, Erika, Michele Correale, Gianmarco Alcidi, Rosanna Pugliese, Sara Ioannoni, Matteo Romano, Gianpaolo Palmieri, Matteo Di Biase, Natale Daniele Brunetti, and Massimo Iacoviello.
2023. "Introduction of SGLT2 Inhibitors and Variations in Other Disease-Modifying Drugs in Heart Failure Patients: A Single-Centre Real-World Experience" Clinics and Practice 13, no. 5: 1015-1024.
https://doi.org/10.3390/clinpract13050090
APA Style
Tabella, E., Correale, M., Alcidi, G., Pugliese, R., Ioannoni, S., Romano, M., Palmieri, G., Di Biase, M., Brunetti, N. D., & Iacoviello, M.
(2023). Introduction of SGLT2 Inhibitors and Variations in Other Disease-Modifying Drugs in Heart Failure Patients: A Single-Centre Real-World Experience. Clinics and Practice, 13(5), 1015-1024.
https://doi.org/10.3390/clinpract13050090